The Spell Brigade on VpeSports is a co-op roguelike with magical chaos. Play with friends, create unique builds, and get a free Steam account to get started.

The ending is the main attraction of Tarkov 1.0, finally letting players experience the full story and make their way out of Tarkov in an exciting finale on a new map. Terminal is the final roadblock ...

Forbes contributors publish independent expert analyses and insights. Mike Stubbs covers esports, competitive games and the creator economy. Escape From Tarkov has officially launched with the 1.0 ...

Ford is rolling out a new dealership design, 'Ford Signature 2.0,' to create a more welcoming, hotel-like experience. This new approach emphasizes hospitality and lower sales pressure, based on ...

Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and began doing so professionally circa 2010. If he was forced to pick a favorite ...

Coming just a few weeks after its previous update, Hyrule Warriors: Age of Imprisonment is set to receive a new update later this week that will add a new “Forbidden” difficulty mode, some extra ...

Things are about to get messy for free, over-the-air TV. This week, the Federal Communications Commission (FCC) passed a notice of proposed rulemaking that’s designed to allow broadcast TV stations to ...

This past week, Microsoft held an online OneDrive event at which it announced several new Copilot-powered AI features coming soon to OneDrive on the web, Windows 11, and mobile. One of those features, ...

As a diehard enthusiast of video games, Ediz Guner has been attentively following the ebbs and flows of the gaming industry for a long period of time. This, coupled with his hobby of extensively ...

GameSpot may get a commission from retail offers. Palworld developer Pocketpair has announced that the game will leave early access and launch its 1.0 version in 2026. Additionally, the studio teased ...

Orforglipron, a small-molecule, nonpeptide oral glucagon-like peptide-1 (GLP-1) receptor agonist, is being investigated as a treatment for obesity. In this phase 3, multinational, randomized, ...